AURELIUS sells the remaining parts of its public-sector business in Great Britain and Northern Ireland

Aurelius Capital

Munich / London, February 5, 2019 – AURELIUS Equity Opportunities SE & Co. KGaA (ISIN DE000A0JK2A8) will sell the remaining parts of its public-sector business in Great Britain and Northern Ireland. The homecare business in Northern Ireland was sold to the longtime minority shareholder, the Mackle family. The business of community rehabilitation services for the British public authorities (so-called CRCs, Community Rehabilitation Companies) will be transferred in accordance with them to services company Seetec, based in Hockley (Great Britain).

AURELIUS had already sold the homecare business in England, Scotland and Wales to the Health Care Resourcing Group (CRG), based in Prescot (Great Britain), at the end of 2018. With the current sale, AURELIUS has now withdrawn completely from the business of outsourced services for the public authorities in Great Britain. The further development of this market will largely depend on public budgetary conditions. Government savings constraints have already led to a substantial consolidation of this industry in the past few years.

After being acquired by AURELIUS, these activities were subjected to an extensive restructuring program, including the introduction of a much improved IT infrastructure, the enhancement of service quality, and cost reductions in the areas of personnel, overhead costs and rents.

Categories: News

Tags:

EURAZEO announces the sale of its stake in NEOVIA

Eurazeo

Paris, February 1, 2019 – Eurazeo, Idia, Future French Champions, and Unigrains, Neovia shareholders
since 2015 alongside InVivo (historical majority shareholder), have today announced the effective sale of
all Neovia shares to Archer Daniels Midland Company (NYSE: ADM).

Over the past three years, spurred by Eurazeo and InVivo, its historical shareholder, as well as its
management team, Neovia has undergone an in-depth transformation and accelerated its international
reach, while expanding into high added-value businesses. Over the period, the company carried out more
than 15 acquisitions worldwide, boosting its revenue outside Europe from 52% to nearly 75%. Backed by
its new shareholder, with its highly complementary market positions, Neovia is well positioned to further
its global leadership in animal nutrition.

Transaction sales proceeds for Eurazeo and its investor partners total €225 million, including €170 million
for Eurazeo, representing a return on its initial investment of nearly 2x and an IRR of approximately 20%.

About Eurazeo
Eurazeo is a leading global investment company, with a diversified portfolio of €17 billion in assets under management, including nearly €11 billion from third parties, invested in over 300 companies. With its considerable private equity, venture capital, real estate, private debt and fund of funds expertise, Eurazeo accompanies companies of all sizes, supporting their development through the commitment of its 235 professionals and by offering deep sector expertise, a gateway to global markets, and a responsible and stable foothold for transformational growth. Its solid institutional and family shareholder base, robust financial structure free of structural debt, and flexible investment horizon enable Eurazeo to support its companies over the long term. Eurazeo has offices in Paris, New York, Sao Paulo, Buenos Aires, Shanghai, London, Luxembourg,
Frankfurt and Madrid.

• Eurazeo is listed on Euronext Paris.
• ISIN: FR0000121121 – Bloomberg: RF FP – Reuters: EURA.PA

Categories: News

Coller Capital’s fund enters a strategic relationship with Liquid Stock

Coller Capital

Liquid Stock (“Liquid”) today announced the launch of a fully independent, institutionally backed firm providing liquidity to employees and stockholders of privately held companies.  This strategy will align the interests of employees and shareholders by converting option holders into owners, providing companies with an alternative to tender offers and offering employees and shareholders full value for their stock.  Liquid’s team brings together a multi-disciplinary approach of leaders in liquidity solutions, venture capital and private equity investing, to provide liquidity to individual counterparties. Liquid is well-positioned to become the leading source of capital for private companies looking to provide liquidity to their employees through tax efficient, company-wide share purchase programs.

Funds managed by Goldman Sachs Asset Management, Morgan Stanley AIP and Coller Capital have entered into a strategic relationship with Liquid, making substantial capital commitments to Liquid’s fund.

Robert Pitti, Founding Partner of Liquid commented, “Our team brings a long history with a strong track record of collaboratively solving the challenges faced by private companies and their employees, as well as a strong understanding of their businesses.  Our strategic investors provide Liquid the ability to scale immediately to meet the needs of even the largest private companies, as well as a deep understanding of the global markets.”

Harold Hope, Managing Director and Global Head of Goldman Sachs Asset Management’s Vintage Funds commented, “Liquid’s depth of experience, diversity of skills and quality of team uniquely positions them as the liquidity provider of choice for employees and stockholders of privately held companies. As venture-backed companies are staying private for longer, we believe the Liquid offering provides an important liquidity tool for these stakeholders.”

Jeremy Coller, Chief Investment Officer of Coller Capital, said, “This is an innovative product that enhances liquidity options for those who work and invest in privately held businesses. We’re pleased to be partnering with Liquid in this exciting development.”

About Liquid Stock

Liquid Stock, headquartered in San Francisco and Los Angeles, is the first fully independent, institutionally backed firm, providing liquidity to employees and stockholders of privately held companies. Liquid intends to become the leading source of liquidity for employees and investors holding valuable, illiquid assets, and for companies looking to address their employees’ liquidity needs through tax efficient share purchase programs. More information about Liquid can be found at www.liquidstock.com.

Categories: News

Tags:

CAMPUS ENERGY PARTNERS takes ownership of certain ALTAGAS ENERGY INFRASTRUCTURE and supply assets

Birch Hill

Calgary, AB – February 1, 2019: Campus Energy Partners LP (“Campus Energy” or the “Company”)
today announced the closing of the acquisition of certain natural gas midstream, power, and commercial
and industrial marketing assets from AltaGas Ltd. (“AltaGas”).
Campus Energy Partners is a newly formed private entity owned by Birch Hill Equity Partners (“Birch
Hill”).

The Company’s energy infrastructure assets are located throughout Western Canada and include two
natural gas transmission pipeline systems, five natural gas gathering and processing facilities, an LNG
processing facility, and two power peaking units. Its energy supply solutions include providing natural
gas and electricity to customers in British Columbia, Alberta, Saskatchewan, Manitoba and Ontario.
Campus Energy will be headquartered in Calgary and led by Jeremy Baines, newly appointed President
and Chief Executive Officer. Baines was formerly Senior Vice President of Strategic Projects with
AltaGas.

“We are a new company at Campus Energy, but we also have a long history of serving customers with
energy solutions. As Campus Energy, we will continue to operate safely, provide customers with creative
solutions, and be a contributor to the communities where we operate. We’ll also be actively seeking
opportunities to grow our business both organically and through acquisitions,” said Baines.
“It’s an exciting time for Birch Hill when we add a new partner company. We look forward to working
with Jeremy and his team of talented people at Campus Energy to build on their past successes as part of
AltaGas. The new company has a strong base of assets and operations to build from so we look forward
to expanding their customer reach and supporting their future growth plans,” said Michael Salamon, a
Partner with Birch Hill.

Additional information on Campus Energy can be found at www.campusenergy.ca.

About Birch Hill Equity Partners
With over $3 billion in capital under management, 17 partner companies and 45 fully realized investments
since 1994, Birch Hill is the leader in long-term value creation in the Canadian mid-market. For more
information about Birch Hill Equity Partners, please visit www.birchhillequity.com.

Contact:
Jeremy Baines – President and CEO – Campus Energy Partners
(403) 206-2832

Categories: News

Tags:

Investor AB supports Electrolux proposal to split the Group

Investor

2019-02-01 07:33 GMT+01

As announced yesterday, Electrolux Board of Directors has initiated work in order to propose that a shareholders meeting decides to separate its professional appliances business, Electrolux Professional, into a new company and to distribute it to the shareholders of AB Electrolux in 2020. As the largest owner of Electrolux, Investor supports this proposal.

“We believe that the intended split will further sharpen focus and add customer value both in Electrolux core consumer business and in the professional appliances business. A separation will create two strong platforms with good prospects for profitable growth and long-term value creation. Upon completion of the split both companies will be listed core investments within Investor”, comments Johan Forssell, Investor’s President and CEO.

Investor is Electrolux largest owner, holding 16.4 per cent of the capital and 28.3 per cent of the votes.

For further information:

Viveka Hirdman-Ryrberg, Head of Corporate Communication and Sustainability,
Phone +46 70 550 3500
viveka.hirdman-ryrberg@investorab.com

Magnus Dalhammar, Head of Investor Relations,
Phone +46 73 524 2130
magnus.dalhammar@investorab.com

Our press releases can be accessed at www.investorab.com

Investor, founded by the Wallenberg family a hundred years ago, is the leading owner of high quality Nordic-based international companies. Through board participation, our industrial experience, network and financial strength, we strive to make our companies best-in-class. Our holdings include, among others, ABB, Atlas Copco, Ericsson, Mölnlycke and SEB.

Categories: News

Tags:

Broodstock Capital invests in Åkerblå

Broodstock Capital

1 February 2019 – Seafood investor Broodstock Capital invests in Norwegian marine
health player Åkerblå. The objective is to strengthen the service offering and increase
customer benefit through further investments in knowledge, expertise and increased
R&D focus, as well as ramping up Åkerblå’s international efforts.
Åkerblå was established in 1991 under the name Havbrukstjenesten. The company
subsequently rebranded to Åkerblå in 2014. It provides consulting and certification services
within fish health, environment and technical operations, primarily for fish farming
companies. Åkerblå also provides services to operators of wellboats and service vessels,
pharmaceutical companies, institutions within research and education, as well as public
sector bodies.

Åkerblå is the only company in the world with accreditation status for control of fish
health, and the only player in Norway with accreditation status for both fish health control,
environmental surveys and technical services.
“Åkerblå has a highly competent team that has succeeded with its strategy of establishing a
local presence close to its customers. The company has grown steadily, year after year, and
we are proud to become a co-owner. Broodstock Capital’s strategy is to invest in market
leaders within niches of the supply chain to the seafood industry, and to own and develop
businesses in partnership with founders, management and existing owners. The Åkerblå
investment represents the core of Broodstock Capital’s investment strategy,” says Simen
Landmark, partner at Broodstock Capital.
Today’s owners remain
Åkerblå employs approximately 85 people across 13 regional offices along the Norwegian
coast, with its headquarters at Frøya in Trøndelag, Norway. In 2018, the company had
revenues of approximately NOK 100 million and delivered a positive operating profit margin
in line with previous years.

Broodstock Capital’s investment consists of a combination of acquisition of shares and an
equity injection to contribute to further development and growth of Åkerblå, both in
Norway and Internationally. Current owners and Broodstock Capital have in total made NOK
20 million in new capital available to Åkerblå.
Following completion of the transaction, Broodstock Capital will own half of the company.
Current owners Arild Kjerstad, Asgeir Østvik and Roger Sørensen will own the other half.
Roger Sørensen continues in his role as CEO of the company.
“Broodstock Capital contributes with both expertise and capital. This gives us the
opportunity to invest even more in competence, R&D and system improvements that will
benefit our customers. Amongst other things, we want do digitalise even more of our
services, which will make our clients’ data even more accessible to them,” says Roger
Sørensen, CEO of Åkerblå.
Sørensen also refers to the fact that the company recently established a dedicated R&D
department to become an even more attractive cooperation partner for the industry,
universities and research institutions.
“We will ramp up our commitment to further developing our highly skilled professionals,
both through competence-enhancing measures and development of new technology within
all our service areas,” Roger Sørensen adds.
Targets international growth

Today, the majority of Åkerblå’s business is related to the Norwegian aquaculture industry.
Outside Norway, the company has operations in Iceland, Canada and Spain. As new owners
enter the company, the ambition is to increase its international presence.
“Åkerblå’s competence and systems are transferable to other aquaculture markets. Our
ambition is to develop the world’s leading competence hub for knowledge-based marine
health services. Broodstock Capital has significant international activity through our
portfolio companies. We anticipate that Åkerblå will capitalise on this network to fast-track
entry into new markets and further strengthen its position in countries already present,”
says Håkon Aglen Fredriksen, partner at Broodstock Capital.
Broodstock Capital’s Håkon Aglen Fredriksen and Simen Landmark will join the Åkerblå
board of directors. Pål Kristian Moe, partner of Trondheim-based advisory firm Impello
Management becomes chairman of the board, while Arild Kjerstad and Asgeir Østvik
continues as members of the board of directors.
Broodstock Capitals funds focus exclusively on investments in small and medium sized
businesses within the seafood industry in general and in the fish supplier industry
specifically. In addition to its investment in Åkerblå, Broodstock Capital has invested in net
cleaning robot supplier MPI – Multi Pump Innovation, RAS system supplier Billund
Aquaculture AS, seafood software company Maritech Systems AS, and water treatment
company NP Innovation AB.

For further information, please contact:
Simen Landmark, partner at Broodstock Capital, tel: +47 45 22 46 48, e-mail: slb@broodstock.no
Håkon Aglen Fredriksen, partner at Broodstock Capital, tel: +47 90 13 01 85, e-mail: haf@broodstock.no
Roger Sørensen, CEO of Åkerblå, tel: +47 91 53 71 23, e-mail: roger.sorensen@akerbla.no

Categories: News

Tags:

The AFT Micromechanics Company joins the Acrotec Group

Castik Capital

Acrotec announces the entrance of AFT Micromechanics into their group.

Acrotec strengthens their diversification strategy with the addition to their group of a new company that specialise in the medical field. M Frésard, General Director of AFT Micromechanics who will remain at the head of his company, looks forward to this important move for his company. ” I am extremely happy to join the Acrotec group who will enable us to continue to advance the

Since its creation in 1997, AFT Micromechanics has specialised in the production of implants for orthopaedic and dental surgery as well as in the fields of urology, ENT and ophthalmology.

AFT benefits from extremely high-performance machining technology that guarantees impeccable quality and advantageous production costs. Since 2014, AFT has a 3D printing system for tool production and for the fast manufacturing of prototypes.

M François Billig, President of the Acrotec Group explains the logic behind this new development: “The acquisition of AFT Micromechanics is consistent with our industrial diversification plans by expanding our presence in the high precision medical field”.

 

– ENDS –

 

For further information please contact:

M.Michele Caracciolo – Tél. +41 77 410 35 60 – mcb@agencecrp.ch

About AFT Micromechanics :

Located in Fillinges, Haute Savoie (France), the company is situated along the Arve valley. Specialists for over 20 years in the machining of medical devices, they meet all the requirements of this market in order to guarantee an optimal level of quality and continual improvement, AFT Micromechnics are registered with FDA (Food and Drug Administration aux Etats-Unis). The company is certified ISO 13485/2016. www.aft-micromecanique.fr

 

About the Acrotec Group :

Acrotec is an independent group created by micromechanical professionals. Their main objective is to be the preferred subcontractor offering a wide range of precision component manufacturing processes. Their strategy is both to provide quality products « Swiss Made » to the entire watch-making industry as well as to the automotive, medical, jewellery and aeronautic industries. Acrotec distinguish themselves by their extent of know-how  provided under one roof, in their precision machining (CNC turning, multi-spindle CNC profile-turning, cam profile-turning, 3 & 5 axes milling, micro- profile-turning, transfer and machining of precious metals), by their support processes (surface treatment, gearing, assembling, heat treatment, laser decorating and engraving) and by their specific processes (UV-Liga component manufacturing, EDM, synthetic stone machining, laminating, spring shaping, design and manufacturing of machines and tooling, Silicon etching by DRIE process).  Today, the group has over 800 employees. www.acrotec.ch

Categories: News

Tags:

DIF consortium reaches financial close on Liège Tram PPP

DIF

Schiphol, 31 January 2019 – DIF is pleased to announce that the Tram’Ardent consortium, comprising DIF Infrastructure V (80%), French civil construction firm Colas (10%) and Spanish rolling stock manufacturer Construcciones y Auxiliar de Ferrocarriles (CAF, 10%), has reached financial close on the Liège Tram PPP in Belgium.

This availability-based public-private partnership contract with Opérateur du Transport de Wallonie, the regional public transport company, involves the design, building, financing and maintenance of a tram line in the centre of Liège between Sclessin, Coronmeuse and Bressoux Station. It includes circa 12 km of rail track (of which over 3 km catenary-less), 21 stations, 20 trams, a maintenance depot, 2 park-and-ride facilities and improvements to the surrounding urban area. Construction will start immediately, with completion expected in the second half of 2022. Thereafter the consortium will maintain the project for circa 27 years, until 2050.

Total funding for the project amounts to €429 million, including long-term debt secured from the European Investment Bank (EIB), Belfius, BBVA, Natixis, AG Insurance and Talanx. The EIB will fund half of the term loan, totalling €193 million, backed by the European Fund for Strategic Investments (EFSI).

Managing Partner of DIF, Wim Blaasse, added: “DIF is exited to invest in this landmark project, which will benefit the community of Liège by increasing mobility whilst decreasing carbon emissions. It is the result of our strong relationship with both Colas and CAF, with each of whom we are successfully pursuing other opportunities around the globe.”

Advisers to the consortium are Natixis (financial), DLA Piper (legal), Loyens & Loeff (tax & accounting) and BDO (model audit). Advisors to the lenders are Loyens & Loeff (legal), Clifford Chance (EIB legal), Infrata (technical) and Aon (insurance).

About DIF
DIF is an independent infrastructure fund manager, with €5.6 billion of assets under management across seven closed-end infrastructure funds and several co-investment vehicles. DIF invests in greenfield and brownfield infrastructure assets located primarily in Europe, North America and Australasia through two complementary strategies:

  • DIF Infrastructure V targets equity investments in public-private partnerships (PPP/PFI/P3), concessions, regulated assets and renewable energy projects with long-term contracted or regulated income streams that generate stable and predictable cash flows.
  • DIF Core Infrastructure Fund I targets equity investments in small to mid-sized infrastructure assets in the energy, transportation and telecom sectors with mid-term contracted income streams that generate stable and predictable cash flows.

DIF has a team of over 110 professionals, based in eight offices located in Schiphol (the Netherlands), Frankfurt, London, Luxembourg, Madrid, Paris, Sydney and Toronto. Please visit www.dif.eu for further information.

Contact:
Allard Ruijs, Partner
Email: a.ruijs@dif.eu

Categories: News

Tags:

Rovers Medical Devices Welcomes Smile Invest as Partner for its next phase of growth

Smile Invest announces today that it acquires a majority stake in Rovers Medical Devices (“Rovers”), global market leader in development and production of medical cell-sampling devices. The investment will facilitate the next phase of growth of the company with a focus on product development and leveraging the company’s global sales capabilities.

Rovers is a market leader in the development and production of medical devices used for cytological analysis, bacteriological-, HPV-, viral- and DNA testing. The devices are mainly used for screening of cervical cancer. From its headquarters and production facility in Oss, the Netherlands, Rovers supplies customers in over 50 countries worldwide. Its devices have been used to screen over half a billion women.

CEO and shareholder Meindert Zwart positioned the company as a key player in the market for medical cell-sampling devices. Rovers’ devices have consistently obtained excellent reviews in medical journals and are used together with testing kits from major medical technology companies. With its state-of-the-art production facilities Rovers is able to supply its customers globally while adhering to local regulatory requirements.

Meindert Zwart will stay on board and will reinvest alongside Smile Invest: “The arrival of Smile Invest as new investor offers us the possibility to strengthen our current market position and prepare the organization for further growth. Smile Invest’s expertise in the healthcare sector and access to successful medtech entrepreneurs is of huge value to Rovers.”

Ivo Vincente and Thomas Dewever, managing partners at Smile Invest add: “Rovers Medical Devices has positioned itself as a reference in its market. With the development of new self-sampling devices Rovers is able to tap into a promising market opportunity. Over 40% of women in developed countries are still not regularly being tested for cervical cancer. Rovers can play an important role in lowering the hurdle for screening in developed markets and could also provide medical professionals with tools to bring these tests to developing countries. We look forward to supporting Rovers in a new phase of growth.”

About Smile Invest:
Smile Invest is a European evergreen investment fund with €350 million of assets under management and a long term focus on innovative growth companies in the Benelux financed by around 40 entrepreneurial families. From its offices in Leuven and The Hague the team supports entrepreneurs and management to realise their growth plans based on many years of experience, expertise and an extended network.

Contact:

NL: Ivo Vincente, managing partner Smile Invest – ivo.vincente@smile-invest.com +31 70 76 30 151
Be: Thomas Dewever, managing partner Smile Invest – thomas.dewever@smile-invest.com +32 16 24 42 32

Categories: News

Tags:

Permira Partners with Hana Group to Support its Expansion

TA associates

TA Associates, which was the First Institutional Investor in Hana Group, to Exit

LONDON, PARIS, NEW YORK – Hana Group (“Hana” or “the Company”) has today announced that Permira, the global private equity firm, has entered into a definitive agreement whereby a company backed by the Permira funds will invest in Hana, in partnership with the founders and the management, who will substantially re-invest in the Company. The transaction sees TA Associates, which was the first institutional investor in Hana, exiting its investment.

Founded in 2012 by Laurent Boukobza and Jacques Attal, Hana is a global provider of freshly prepared sushi “on the go” through its 900 points of sale in grocery retailers across 12 markets. Its core geographies are the United States and France. In addition, Hana operates in the UK, Spain, Italy, Portugal, Belgium, Czech Republic, Romania and Luxembourg. The business now employs over 4,000 people globally. Hana Group is a strategic partner to its customers. It has grown rapidly over the last seven years through both organic and external growth, including the transformative acquisition of Peace Dining in the United States.

Yann Coleou, CEO, Hana Group, said: “The management team is very pleased to welcome the Permira funds as a new investor. This signals a new stage in Hana’s growth. I am confident that Permira’s involvement will be beneficial for our clients, customers and our team.”

Jacques Attal, founder of Hana Group, said: “TA Associates have been strong partners through the investment period. They have supported us strategically, which has enabled the Company to become a global leader, and also embedded a culture of innovation which lays a strong foundation for our partnership with Permira.”

Alexandre Margoline, Partner and Head of France at Permira said: “Jacques, Laurent and Yann have already developed Hana into a uniquely positioned business with global reach. We are very excited by the breadth of growth opportunities ahead, including new geographies, channels and clients. Leveraging its core capabilities across both B2B and B2C propositions, Hana is the perfect platform from which to build a global provider of freshly prepared meal solutions. We are looking forward to working with Yann and his team to support the next chapter in Hana’s growth and success.”

Tara Alhadeff, Principal in Permira’s Global Consumer Team, said: “Global demand for sushi is growing, driven by consumers’ demand for healthy and convenient meals. At the same time, retailers are looking to introduce more theatre and experience into their stores. With its in-store chefs preparing fresh sushi, Hana addresses both of these trends. We believe that Hana’s relentless focus on innovation, customer service and consumer experience, will continue to fuel growth and increasingly strategic collaboration with retail partners.”

Patrick Sader, Managing Director at TA Associates, added: “We are very pleased to have been able to help Hana Group in its international development. Our partnership with the founders of Hana Group is a perfect example of TA Associates’ investment philosophy. Hana Group is a unique business defined by the quality and diversity of its offering and its execution capacity worldwide. We would like to thank Hana Group’s founders and managers for their leadership, extreme focus on quality and innovation, and exceptional commitment, which today make Hana Group a leader in the premium food wholesale distribution sector.”

This transaction is expected to complete in Q2-2019.

Hana Group was advised by Rothschild and KPMG for the financial aspects and LATHAM & WATKINS for the legal aspects, and the Boston Consulting Group. Its managers are advised by McDermott, Gide and Callisto.

Permira was advised by Cambon Partners as advisory bank, McKinsey, Simon Kucher and Alix Partners for commercial diligence, Weil Gotshal & Manges for legal matters, Alvarez & Marsal for financial due diligence, PwC for tax and HR matters, and Linklaters for structuring.

About Hana Group
Founded in 2012, Hana Group (“Hana” or “HG”) is a global operator of in-store food kiosks in all retail formats and high traffic areas, offering ultra-fresh food on-the-go prepared by chefs in front of consumers, providing in-store entertainment and continuous product and concept innovation. Initially focused on sushi kiosks, Hana Group has developed other concepts, including pan-Asian food, as well as Italian and Mediterranean cuisines and operates under a portfolio of 14 brands. For more information visit http://hanagroup.eu/.

About Permira
Permira is a global investment firm that finds and backs successful businesses with growth ambition. Founded in Europe in 1985, the firm advises funds with a total committed capital of approximately €33 billion. The Permira funds make long-term control buyout investments and strategic minority investments in companies with the ambition of transforming their performance and driving sustainable growth. Over more than three decades, the Permira funds have made over 250 private equity investments in five key sectors: Consumer, Financial Services, Healthcare, Industrials and Technology.

The Permira funds have a long track record of successfully investing in consumer companies around the world and have deployed over €8.8bn in the sector since 1997. Investments in the food and food-related sectors have included Sushiro (Japan’s leading value sushi chain), BFY Foods, La Piadineria and Iglo Group. In France the Permira funds are also shareholders of Vacanceselect and Exclusive Group. Permira employs over 250 people in 14 offices across Europe, North America and Asia. For more information visit www.permira.com.

About TA Associates
TA Associates is one of the largest and most experienced global growth private equity firms. Focused on five target industries – technology, healthcare, financial services, consumer and business services – TA invests in profitable, growing companies with opportunities for sustained growth, and has invested in more than 500 companies around the world. Investing as either a majority or minority investor, TA employs a long-term approach, utilizing its strategic resources to help management teams build lasting value in growth companies. TA has raised $24 billion in capital since its founding in 1968 and is committing to new investments at the pace of $2 billion per year. The firm’s more than 85 investment professionals are based in Boston, Menlo Park, London, Mumbai and Hong Kong. For more information visit www.ta.com.

Categories: News

Tags: